These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 26343367)

  • 41. HIV-1 and human genetic variation.
    McLaren PJ; Fellay J
    Nat Rev Genet; 2021 Oct; 22(10):645-657. PubMed ID: 34168330
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New insights into host factors in HIV-1 pathogenesis.
    Rowland-Jones S; Pinheiro S; Kaul R
    Cell; 2001 Feb; 104(4):473-6. PubMed ID: 11239405
    [No Abstract]   [Full Text] [Related]  

  • 43. Immunopathogenesis of HIV-1 infection.
    Cao H; Walker BD
    Clin Dermatol; 2000; 18(4):401-10. PubMed ID: 11024307
    [No Abstract]   [Full Text] [Related]  

  • 44. Discovery of modulators of HIV-1 infection from the human peptidome.
    Münch J; Ständker L; Forssmann WG; Kirchhoff F
    Nat Rev Microbiol; 2014 Oct; 12(10):715-22. PubMed ID: 25110191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Host-pathogen interactions in the backyard of HIV-1 infection.
    Cimarelli A
    Virologie (Montrouge); 2020 Dec; 24(6):32-35. PubMed ID: 33441285
    [No Abstract]   [Full Text] [Related]  

  • 46. [Host-pathogen interactions in the backyard of HIV-1 infection].
    Cimarelli A
    Virologie (Montrouge); 2020 Dec; 24(6):349-352. PubMed ID: 33441286
    [No Abstract]   [Full Text] [Related]  

  • 47. Data vs. dogma: HIV-1 integrations driving clonal selection.
    Baum C
    Mol Ther; 2014 Sep; 22(9):1557-8. PubMed ID: 25186554
    [No Abstract]   [Full Text] [Related]  

  • 48. New insights into HIV impact on hematopoiesis.
    Akkina R
    Blood; 2013 Sep; 122(13):2144-6. PubMed ID: 24072846
    [No Abstract]   [Full Text] [Related]  

  • 49. Lessons from reservoirs.
    Nat Med; 2017 Aug; 23(8):899. PubMed ID: 28777792
    [No Abstract]   [Full Text] [Related]  

  • 50. The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4(+) T-cells.
    Kumar NA; Cheong K; Powell DR; da Fonseca Pereira C; Anderson J; Evans VA; Lewin SR; Cameron PU
    Retrovirology; 2015 Sep; 12():76. PubMed ID: 26362311
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.
    Søgaard OS; Graversen ME; Leth S; Olesen R; Brinkmann CR; Nissen SK; Kjaer AS; Schleimann MH; Denton PW; Hey-Cunningham WJ; Koelsch KK; Pantaleo G; Krogsgaard K; Sommerfelt M; Fromentin R; Chomont N; Rasmussen TA; Østergaard L; Tolstrup M
    PLoS Pathog; 2015 Sep; 11(9):e1005142. PubMed ID: 26379282
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A new hypothesis on HIV cure.
    Hladik F
    F1000Res; 2015; 4():77. PubMed ID: 26380071
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Epigenetic control of HIV-1 post integration latency: implications for therapy.
    Kumar A; Darcis G; Van Lint C; Herbein G
    Clin Epigenetics; 2015; 7():103. PubMed ID: 26405463
    [TBL] [Abstract][Full Text] [Related]  

  • 54. BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency.
    Pache L; Dutra MS; Spivak AM; Marlett JM; Murry JP; Hwang Y; Maestre AM; Manganaro L; Vamos M; Teriete P; Martins LJ; König R; Simon V; Bosque A; Fernandez-Sesma A; Cosford ND; Bushman FD; Young JA; Planelles V; Chanda SK
    Cell Host Microbe; 2015 Sep; 18(3):345-53. PubMed ID: 26355217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mixed effects of suberoylanilide hydroxamic acid (SAHA) on the host transcriptome and proteome and their implications for HIV reactivation from latency.
    White CH; Johnston HE; Moesker B; Manousopoulou A; Margolis DM; Richman DD; Spina CA; Garbis SD; Woelk CH; Beliakova-Bethell N
    Antiviral Res; 2015 Nov; 123():78-85. PubMed ID: 26343910
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Controlling HIV-1: Non-Coding RNA Gene Therapy Approaches to a Functional Cure.
    Ahlenstiel CL; Suzuki K; Marks K; Symonds GP; Kelleher AD
    Front Immunol; 2015; 6():474. PubMed ID: 26441979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HIV persistence in the setting of antiretroviral therapy: when, where and how does HIV hide?
    Kulpa DA; Chomont N
    J Virus Erad; 2015 Apr; 1(2):59-66. PubMed ID: 26448966
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adipose Tissue Is a Neglected Viral Reservoir and an Inflammatory Site during Chronic HIV and SIV Infection.
    Damouche A; Lazure T; Avettand-Fènoël V; Huot N; Dejucq-Rainsford N; Satie AP; Mélard A; David L; Gommet C; Ghosn J; Noel N; Pourcher G; Martinez V; Benoist S; Béréziat V; Cosma A; Favier B; Vaslin B; Rouzioux C; Capeau J; Müller-Trutwin M; Dereuddre-Bosquet N; Le Grand R; Lambotte O; Bourgeois C
    PLoS Pathog; 2015 Sep; 11(9):e1005153. PubMed ID: 26402858
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proteomic analysis of HIV-1 Gag interacting partners using proximity-dependent biotinylation.
    Le Sage V; Cinti A; Valiente-Echeverría F; Mouland AJ
    Virol J; 2015 Sep; 12():138. PubMed ID: 26362536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of Genes Whose Expression Profile Is Associated with Non-Progression towards AIDS Using eQTLs.
    Spadoni JL; Rucart P; Le Clerc S; van Manen D; Coulonges C; Ulveling D; Laville V; Labib T; Taing L; Delaneau O; Montes M; Schuitemaker H; Noirel J; Zagury JF
    PLoS One; 2015; 10(9):e0136989. PubMed ID: 26367535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.